1040 - Growing Demand for Menopausal Hormone Therapies Brings Excitement—and New Concerns
Episode Description
About this episode:
Following the FDA's removal of black box warnings for hormone therapy drugs, demand has skyrocketed for menopause treatments. In this episode: why this explosion in popularity marks a trend in the right direction for quality reproductive care while also raising concerns about "menowashed" products and blanket prescribing of hormonal interventions.
Guests:
Dr. Wendy L. Bennett, MPH, is a primary care doctor and associate professor with appointments at the Johns Hopkins Bloomberg School of Public Health and School of Medicine.
Dr. Tina Zhang is a primary care doctor and assistant professor at the Johns Hopkins University School of Medicine.
Host:
Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs.
Show links and related content:
-
Why the 'mad scramble' to fill hormone therapy prescriptions for menopause—NPR
-
FACT SHEET: FDA Initiates Removal of "Black Box" Warnings from Menopausal Hormone Replacement Therapy Products—U.S. Department of Health and Human Services
-
What Is a Black Box Warning?—Johns Hopkins Bloomberg School of Public Health
-
De-medicalizing Menopause—Public Health On Call (March 2024)
Transcript information:
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:
-
Here's our RSS feed
Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
Listen On
